Myocor Overview
- Founded
-
1996
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Myocor General Information
Description
Developer of devices to treat mitral valve insufficiency and congestive heart failure. The company develops medical devices that alter the physiology of the heart failure disease process and help clinical outcomes for late stage heart failure patients. The firm offers the Coapsys, which uses pads and a string passed through the heart with tension applied to reshape an enlarged heart and force a leaky mitral valve to work better.
Contact Information
Primary Industry
Therapeutic Devices
Acquirer
Primary Office
- 13300 67th Avenue North
- Osseo, MN 55311
- United States
+1 (763) 000-0000
Myocor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 31-Dec-2008 | 000.00 | Completed | Startup | ||
| 5. Convertible Debt | 05-May-2008 | 00.000 | 000.00 | Completed | ||
| 4. Later Stage VC (Series D) | 21-Dec-2004 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Later Stage VC (Series C) | 03-May-2001 | 000.00 | 0000 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC | 08-Jan-2001 | $11M | $11.5M | 000.00 | Completed | Startup |
| 1. Angel (individual) | 01-Apr-1997 | $500K | $500K | Completed | Startup |
Myocor Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00.000 | ||
| Series C | 000,000 | 00.000000 | 000 | 000.0 | 00.0 | 00.000 | ||
| Series B | 349,700 | $0.010000 | $20 | $10 | $6.8 | 5.73% | ||
| Series A | 445,400 | $0.010000 | $9 | $4.5 | $4.1 | 5.45% |
Myocor Patents
Myocor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-1219401-A | Methods and devices for improving cardiac function in hearts | Inactive | 21-Oct-1999 | 0000000000 | |
| US-20030045771-A1 | Heart wall tension reduction devices and methods | Inactive | 02-Jan-1997 | 0000000000 | 00 |
Myocor Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Affinity Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Alta Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Coral Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| IVP | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Patricia Industries | PE/Buyout | Minority | 000 0000 | 000000 0 |